Stifel Financial Corp Emergent Bio Solutions Inc. Transaction History

Stifel Financial Corp

  • $106 Billion
  • Q3 2025

A detailed history of Stifel Financial Corp transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 20,194 shares of EBS stock, worth $204,161. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,194
Holding current value
$204,161
% of portfolio
0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025
BUY
$5.63 - $9.32 $113,692 - $188,208
20,194 New
20,194 $178,000
Q3 2024

Nov 14, 2024
BUY
$5.72 - $14.77 $65,551 - $169,264
11,460 New
11,460 $95,000
Q1 2022

May 13, 2022
SELL
$36.48 - $52.22 $384,426 - $550,294
-10,538 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$33.11 - $55.01 $9,966 - $16,558
301 Added 2.94%
10,538 $458,000
Q3 2021

Nov 15, 2021
BUY
$50.07 - $66.05 $306,778 - $404,688
6,127 Added 149.08%
10,237 $512,000
Q2 2021

Aug 13, 2021
SELL
$56.61 - $80.46 $120,239 - $170,897
-2,124 Reduced 34.07%
4,110 $258,000
Q1 2021

May 14, 2021
BUY
$86.23 - $125.19 $76,572 - $111,168
888 Added 16.61%
6,234 $578,000
Q4 2020

Feb 12, 2021
SELL
$79.17 - $111.47 $330,138 - $464,829
-4,170 Reduced 43.82%
5,346 $479,000
Q3 2020

Nov 16, 2020
SELL
$81.91 - $134.94 $428,389 - $705,736
-5,230 Reduced 35.47%
9,516 $984,000
Q2 2020

Aug 14, 2020
SELL
$54.33 - $89.52 $139,899 - $230,514
-2,575 Reduced 14.87%
14,746 $1.17 Million
Q1 2020

May 14, 2020
BUY
$49.34 - $68.76 $216,010 - $301,031
4,378 Added 33.83%
17,321 $1 Million
Q4 2019

Feb 13, 2020
SELL
$51.21 - $59.06 $138,215 - $159,402
-2,699 Reduced 17.25%
12,943 $696,000
Q3 2019

Nov 19, 2019
BUY
$40.6 - $57.2 $34,185 - $48,162
842 Added 5.69%
15,642 $817,000
Q3 2019

Nov 13, 2019
BUY
$40.6 - $57.2 $22,817 - $32,146
562 Added 3.95%
14,800 $774,000
Q2 2019

Aug 14, 2019
SELL
$39.92 - $53.86 $103,592 - $139,766
-2,595 Reduced 15.42%
14,238 $690,000
Q1 2019

May 14, 2019
SELL
$48.23 - $66.16 $113,340 - $155,476
-2,350 Reduced 12.25%
16,833 $853,000
Q4 2018

Feb 13, 2019
BUY
$55.63 - $73.24 $185,359 - $244,035
3,332 Added 21.02%
19,183 $1.14 Million
Q3 2018

Nov 13, 2018
SELL
$52.05 - $66.51 $34,769 - $44,428
-668 Reduced 4.04%
15,851 $1.04 Million
Q2 2018

Aug 14, 2018
SELL
$48.33 - $55.64 $115,750 - $133,257
-2,395 Reduced 12.66%
16,519 $831,000
Q1 2018

May 11, 2018
BUY
$44.44 - $54.39 $182,426 - $223,270
4,105 Added 27.72%
18,914 $995,000
Q4 2017

Feb 14, 2018
BUY
$37.77 - $47.75 $46,721 - $59,066
1,237 Added 9.11%
14,809 $689,000
Q3 2017

Nov 13, 2017
BUY
$34.14 - $40.45 $463,348 - $548,987
13,572
13,572 $0

Others Institutions Holding EBS

# of Institutions
191
Shares Held
41.3M
Call Options Held
899K
Put Options Held
256K
View Full List

About Emergent BioSolutions Inc.

EBS Quotes by TradingView
  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $504M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email